Advancements in the PNH Treatment Paradigm
Final 48-Week Results of the APPLY-PNH Trial: Long-Term Efficacy & Safety in Anti-C5-Treated Patients With PNH & Persistent Anemia Undergoing Factor B Inhibition With Oral Iptacopan Monotherapy
By
Insights from 2023 ASH Annual Meeting
FEATURING
Carlos de Castro
By
Insights from 2023 ASH Annual Meeting
FEATURING
Carlos de Castro
Login to view comments.
Click here to Login